Biopsy Devices Market Size, Share, Trends, Growth 2032

Biopsy Devices Market Insights

Zion Market Research has published a report on the global Biopsy Devices Market, estimating its value at USD 23.69 Billion in 2023, with projections indicating that it will reach USD 37.39 Billion by 2032. The market is expected to expand at a compound annual growth rate (CAGR) of 5.2% over the forecast period 2024-2032. The report explores the factors fueling market growth, the hitches that could hamper this expansion, and the opportunities that may arise in the Biopsy Devices Market industry. Additionally, it offers a detailed analysis of how these elements will affect market demand dynamics and market performance throughout the forecast period.

Request Free Sample

Biopsy Devices Market: Synopsis

Biopsy devices are instruments that are utilized for removing cell tissues from human body with a purpose of analyzing them in labs for detecting presence of microorganisms in humans. Now, biopsy equipment also includes vacuum assistance that supports diagnostic accuracy. Furthermore, most common kinds of biopsy equipment include incisional biopsy, excisional biopsy, and needle biopsy. In incisional biopsy a tissue sample is removed from human body and during excisional biopsy a complete lump is removed from area of suspicion. In needle biopsy, either a tissue sample or fluid is removed with help of needle.

Biopsy Devices Market: Growth Dynamics

Surging cases of cancer and occurrence of varied kinds of infections will drive biopsy devices market expansion. Apart from this, massive awareness about breast cancer diagnosis among women will create new avenues of growth for biopsy device industry during forecast period. Product innovations have resulted in growing acceptance of minimally invasive methods, thereby driving market trends. In addition to this, substantial breakthroughs in imaging systems like MRI, CT, and ultrasound will proliferate growth of biopsy devices industry during assessment period.  Furthermore, increase in aging population and launching of new biopsy devices at reduced prices will steer growth of biopsy devices industry in foreseeable future.

Furthermore, rise in utilization of smart biopsy equipment in myriad healthcare applications will drive business landscape. In addition to this, real-time tissue classification of cancerous cells and reduced costs of smart biopsy equipment will produce new growth avenues for biopsy devices market during forecast timeline.

Biopsy Devices Market: Report Scope

Biopsy Devices Market: Regional Landscape

North America To Make Opulent Contributions Towards Overall Market Revenue During 2024-2032

Massive expansion of biopsy devices market in North America during forecast timeframe is due to highest number of biopsies in the U.S. Reportedly, the U.S. FDA comprise of less stricter regulatory approval framework for medical equipment. Apart from this, many of government health schemes are aimed at prompting people for undertaking routine cancer screening. This has led to humungous market penetration in North America. Presence of giant players, access to strong healthcare infrastructure, and easy availability of trained healthcare service providers will drive regional market growth trends.

Biopsy Devices Market Competitive Landscape

Key players profiled in study and impacting industry sphere are

• Hologic Inc.
• Danaher Corporation (Leica Microsystem)
• B. Braun Melsungen AG
• Fujifilm Holdings Corp.
• Argon Medical Devices Inc.
• Becton Dickinson and Company (C.R. Bard Inc.)
• Boston Scientific Corporation
• Cardinal Health Inc.
• Cook Medical Inc.
• Medtronic plc

The global Biopsy Devices Market is segmented as follows:

By Product

• Core Needle Biopsy
• Aspiration Biopsy
• Vacuum Assisted Biopsy

By Application

• Breast Biopsy
• Prostrate Biopsy
• Lung Biopsy

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa